Lysiane Molina

No ORCID on file · 2 papers in corpus · active 1994-1995

Study types

  • review 2
review 1995
·doi:10.1002/1097-0142(19950101)75:1<133::aid-cncr2820750124>3.0.co;2-i
review 1994
·doi:10.1002/1097-0142(19940615)73:12<3073::aid-cncr2820731228>3.0.co;2-#

BACKGROUND: Treatment of myelodysplastic syndromes (MDSs) remains unsatisfactory. A limited number of reports provide contradictory information on whether danazol, a synthetic androgen, may be useful in patients with MDS. METHODS: Between 1…